Yunmin Lu

426 total citations
14 papers, 339 citations indexed

About

Yunmin Lu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Yunmin Lu has authored 14 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Yunmin Lu's work include Phytochemistry and Bioactive Compounds (2 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Cancer Mechanisms and Therapy (2 papers). Yunmin Lu is often cited by papers focused on Phytochemistry and Bioactive Compounds (2 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Cancer Mechanisms and Therapy (2 papers). Yunmin Lu collaborates with scholars based in China. Yunmin Lu's co-authors include Jin‐Shui Zhu, Da Wei, Rui Zhang, Ge Wang, Qun Sun, Guoqiang Qu, Ni‐Wei Chen, Weixiong Chen, Xiaohong Liao and Wei Chen and has published in prestigious journals such as International Journal of Molecular Sciences, Oncotarget and Biomedicine & Pharmacotherapy.

In The Last Decade

Yunmin Lu

14 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yunmin Lu China	11	211	77	56	50	46	14	339
Xiaoduo Dong Singapore	5	244 1.2×	72 0.9×	72 1.3×	51 1.0×	31 0.7×	6	419
Shou‐Mei Wang China	11	294 1.4×	135 1.8×	47 0.8×	52 1.0×	53 1.2×	16	415
Yingchun He China	11	296 1.4×	149 1.9×	76 1.4×	38 0.8×	89 1.9×	35	493
Soo Im Choi South Korea	12	203 1.0×	79 1.0×	68 1.2×	31 0.6×	19 0.4×	24	376
Nianping Chen China	12	284 1.3×	96 1.2×	79 1.4×	42 0.8×	33 0.7×	18	457
Yueling Jin China	11	218 1.0×	108 1.4×	36 0.6×	26 0.5×	25 0.5×	21	353
Youxiang Ding China	12	248 1.2×	82 1.1×	83 1.5×	30 0.6×	20 0.4×	16	399
Shuping Xu United States	13	304 1.4×	96 1.2×	105 1.9×	25 0.5×	28 0.6×	18	467
Qingtao Shi China	10	205 1.0×	72 0.9×	108 1.9×	36 0.7×	20 0.4×	14	367
Luoqi Jia China	9	282 1.3×	120 1.6×	123 2.2×	29 0.6×	42 0.9×	13	452

Countries citing papers authored by Yunmin Lu

Since Specialization

Citations

This map shows the geographic impact of Yunmin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunmin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunmin Lu more than expected).

Fields of papers citing papers by Yunmin Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunmin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunmin Lu. The network helps show where Yunmin Lu may publish in the future.

Co-authorship network of co-authors of Yunmin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yunmin Lu. A scholar is included among the top collaborators of Yunmin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunmin Lu. Yunmin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Fan, Hui‐Ning, Pei Zhu, Yunmin Lu, et al.. (2020). Mild changes in the mucosal microbiome during terminal ileum inflammation. Microbial Pathogenesis. 142. 104104–104104. 14 indexed citations

Lu, Yunmin, et al.. (2016). Eriocalyxin B blocks human SW1116 colon cancer cell proliferation, migration, invasion, cell cycle progression and angiogenesis via the JAK2/STAT3 signaling pathway. Molecular Medicine Reports. 13(3). 2235–2240. 22 indexed citations

Chen, Wei, Weixiong Chen, Jinshui Zhu, Ni‐Wei Chen, & Yunmin Lu. (2016). Potent Anti-Inflammatory Activity of Tetramethylpyrazine Is Mediated through Suppression of NF-k.. PubMed. 15(1). 197–204. 8 indexed citations

Zhang, Rui, Ge Wang, Pengfei Zhang, et al.. (2016). Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway. Journal of Cellular and Molecular Medicine. 21(6). 1117–1127. 47 indexed citations

Zhang, Jing, Ge Wang, Jin‐Shui Zhu, et al.. (2016). Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling. Oncotarget. 7(13). 16180–16193. 60 indexed citations

Qu, Guoqiang, et al.. (2015). Effect of RTKN on progression and metastasis of colon cancer in vitro. Biomedicine & Pharmacotherapy. 74. 117–123. 8 indexed citations

Wang, Ge, Chengcheng Feng, Rui Zhang, et al.. (2015). Toosendanin inhibits growth and induces apoptosis in colorectal cancer cells through suppression of AKT/GSK-3β/β-catenin pathway. International Journal of Oncology. 47(5). 1767–1774. 56 indexed citations

Qu, Guoqiang, et al.. (2015). Silencing of MAP4K4 by short hairpin RNA suppresses proliferation, induces G1 cell cycle arrest and induces apoptosis in gastric cancer cells. Molecular Medicine Reports. 13(1). 41–48. 32 indexed citations

Lu, Yunmin, et al.. (2015). Ponicidin Induces Apoptosis via JAK2 and STAT3 Signaling Pathways in Gastric Carcinoma. International Journal of Molecular Sciences. 16(1). 1576–1589. 25 indexed citations

10.

Lu, Yunmin, Wei Chen, Li Yin, et al.. (2014). Oleanolic acid induces apoptosis of MKN28 cells via AKT and JNK signaling pathways. Pharmaceutical Biology. 52(6). 789–795. 22 indexed citations

11.

Lu, Yunmin, Mei-Ying Zhu, Wei Chen, et al.. (2014). Tetramethylpyrazine improves oxazolone-induced colitis by inhibiting the NF-κB pathway. Clinical and investigative medicine. 37(1). E1–E9. 10 indexed citations

12.

Wei, Da, et al.. (2013). Adalimumab for Crohn’s disease after infliximab treatment failure. European Journal of Gastroenterology & Hepatology. 25(8). 885–891. 19 indexed citations

13.

Wei, Da, et al.. (2013). Efficacy and Safety of Certolizumab Pegol for Crohn’s Disease: A Systematic Review and Meta-Analysis. Advances in Therapy. 30(5). 541–553. 15 indexed citations

14.

Lu, Yunmin, et al.. (2011). Effects of curcumin in intestinal fibrosis of rats and its mechanism. Zhonghua xiaohua zazhi. 31(2). 100–105. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact